Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 101,459
- Estimated value
- $317,567
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Direct
Na Yeon Kim
Insider Reports History
- Reporting-owner location
- Boston, MA
- Latest reporting-owner signature
-
/s/ Phillip D. Torrence, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Na Yeon Kim
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 96,351
- Estimated value
- $301,579
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by The E&Healthcare Investment Fund II
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 62,159
- Estimated value
- $194,558
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by The E&Healthcare Investment Fund No. 7
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 37,373
- Estimated value
- $116,977
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by The E&Healthcare Investment Fund No. 6
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 4,671
- Estimated value
- $14,620
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by E&Investment Inc.
Insider Reports Filed by Na Yeon Kim
4
MTVA
NeuroBo Pharmaceuticals, Inc.
- Report period
- 27 Jul 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 28 Jul 2023, 06:08
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4/A
MTVA
NeuroBo Pharmaceuticals, Inc.
- Report period
- 26 Jul 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Jul 2023, 06:02
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
MTVA
NeuroBo Pharmaceuticals, Inc.
- Report period
- 09 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 13 Jun 2022, 16:14
- Role
- Director, 10%+ Owner
- Next action
- Open filing details